Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Influenza hemagglutinin H7 enables virus entry through dual roles: recognizing sialic acid receptors on host cells via its globular head domain—and facilitating membrane fusion through pH-triggered conformational changes primarily involving its stem region. Its high variability drives immune evasion but also makes it an essential focus for surveillance efforts against emerging zoonotic threats like avian-origin H7N9 strains.
Inhibition of receptor binding; Inhibition of membrane fusion
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Influenza Hemagglutinin Protein (H7) (None).